These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 1424509

  • 1. The activity of metal compounds against aerobic and anaerobic bacteria.
    Chin N, Neu HC.
    Diagn Microbiol Infect Dis; 1992 Aug; 15(6):549-52. PubMed ID: 1424509
    [Abstract] [Full Text] [Related]

  • 2. In vitro antimicrobial activity of the new antibiotic vermisporin.
    Chin NX, Neu HC.
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):755-7. PubMed ID: 1425739
    [Abstract] [Full Text] [Related]

  • 3. Susceptibilities of bovine summer mastitis bacteria to antimicrobial agents.
    Jousimies-Somer H, Pyörälä S, Kanervo A.
    Antimicrob Agents Chemother; 1996 Jan; 40(1):157-60. PubMed ID: 8787898
    [Abstract] [Full Text] [Related]

  • 4. [Antimicrobial susceptibility of clinical isolates of aerobic Gram-positive cocci and anaerobic bacteria in 2006].
    Yamaguchi T, Yoshida I, Itoh Y, Tachibana M, Takahashi C, Kaku M, Kanemitsu K, Okada M, Horikawa Y, Shiotani J, Kino H, Ono Y, Baba H, Matsuo S, Asari S, Toyokawa M, Matsuoka K, Kusano N, Nose M, Murase M, Miyamoto H, Saikawa T, Hiramatsu K, Kohno S, Yanagihara K, Yamane N, Nakasone I, Maki H, Yamano Y.
    Jpn J Antibiot; 2010 Dec; 63(6):431-56. PubMed ID: 21425596
    [Abstract] [Full Text] [Related]

  • 5. [Susceptibility of bacteria isolated from clinical material to ciprofloxacin].
    Namysł E, Galiński J, Szponar M, Piechowicz L.
    Med Dosw Mikrobiol; 1995 Dec; 47(1-2):5-9. PubMed ID: 8523970
    [Abstract] [Full Text] [Related]

  • 6. A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria.
    Fernandes PB, Chu DT, Swanson RN, Ramer NR, Hanson CW, Bower RR, Stamm JM, Hardy DJ.
    Antimicrob Agents Chemother; 1988 Jan; 32(1):27-32. PubMed ID: 3348609
    [Abstract] [Full Text] [Related]

  • 7. [Antimicrobial susceptibility of clinical isolates of aerobic gram-positive cocci and anaerobic bacteria in 2008].
    Yoshida I, Yamaguchi T, Kudo R, Fuji R, Takahashi C, Oota R, Kaku M, Kunishima H, Okada M, Horikawa Y, Shiotani J, Kino H, Ono Y, Fujita S, Matsuo S, Kono H, Asari S, Toyokawa M, Kusano N, Nose M, Horii T, Tanimoto A, Miyamoto H, Saikawa T, Hiramatsu K, Kohno S, Yanagihara K, Yamane N, Nakasone I, Maki H, Yamano Y.
    Jpn J Antibiot; 2012 Feb; 65(1):49-72. PubMed ID: 22808693
    [Abstract] [Full Text] [Related]

  • 8. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria].
    Igari J, Oguri T, Hiramatsu N, Akiyama K, Koyama T.
    Jpn J Antibiot; 2003 Oct; 56(5):437-57. PubMed ID: 14692380
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative in vitro activities of SMT19969, a new antimicrobial agent, against Clostridium difficile and 350 gram-positive and gram-negative aerobic and anaerobic intestinal flora isolates.
    Goldstein EJ, Citron DM, Tyrrell KL, Merriam CV.
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4872-6. PubMed ID: 23877700
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro activity of MDL 62,879 (GE2270 A) against aerobic gram-positive and anaerobic bacteria.
    King A, Bethune L, Phillips I.
    Antimicrob Agents Chemother; 1993 Apr; 37(4):746-9. PubMed ID: 8494370
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of A-16686, a new glycopeptide.
    Neu HC, Neu NM.
    Chemotherapy; 1986 Apr; 32(5):453-7. PubMed ID: 3757587
    [Abstract] [Full Text] [Related]

  • 16. In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms.
    Dubreuil L, Houcke I, Mouton Y, Rossignol JF.
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2266-70. PubMed ID: 8891127
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria.
    Barlam T, Neu HC.
    Antimicrob Agents Chemother; 1984 Apr; 25(4):529-31. PubMed ID: 6732223
    [Abstract] [Full Text] [Related]

  • 20. Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.
    Klietmann W, Focht J, Nösner K.
    Chemioterapia; 1987 Aug; 6(4):243-50. PubMed ID: 3477332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.